Showing results (1731-1740 of 1,887) with videos related to
Sort By:
Pageof 189
Gastroenterology|September 26, 2020
Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead ProgramAmanda Ricciuto, Martine Aardoom, Esther Orlanski-Meyer, et al.Gastroenterology|July 22, 2021
Anti-Microbial Antibody Response is Associated With Future Onset of Crohn's Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic RiskSun-Ho Lee, Williams Turpin, Osvaldo Espin-Garcia, et al.The American Journal of Gastroenterology|June 11, 2009
Phenotypic and genotypic characteristics of inflammatory bowel disease in French Canadians: comparison with a large North American repositoryMamatha Bhat, Geoffrey C Nguyen, Pierre Pare, et al.The American Journal of Gastroenterology|April 19, 2017
Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative DatabasesEric I Benchimol, Charles N Bernstein, Alain Bitton, et al.JAMA Dermatology|September 19, 2019
Association of Serum Ustekinumab Levels With Clinical Response in PsoriasisTeresa Tsakok, Nina Wilson, Nick Dand, et al.The Journal of Investigative Dermatology|April 6, 2007
Filaggrin null alleles are not associated with psoriasisYiwei Zhao, Ana Terron-Kwiatkowski, Haihui Liao, et al.Biorxiv : the Preprint Server for Biology|August 6, 2025
Glucocorticoids unleash immune-dependent melanoma control through inhibition of the GARP/TGF-β axisCharles H Earnshaw, Poppy Dunn, Shih-Chieh Chiang, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 17, 2026
Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose AdalimumabAnika M Valk, Jolinde van Strien, Ninotska Derksen, et al.Journal of Pediatric Gastroenterology and Nutrition|May 7, 2014
Liver enzyme elevations within 3 months of diagnosis of inflammatory bowel disease and likelihood of liver diseaseAlka Goyal, Jeffery S Hyams, Trudy Lerer, et al.Nature Reviews. Gastroenterology & Hepatology|October 3, 2023
Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standardsHolm H Uhlig, Claire Booth, Judy Cho, et al.Pageof 189